The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act." This guidance provides recommendations for industry and review staff on the formal dispute resolution (FDR) and administrative hearings procedures for resolving scientific and/or medical disputes between the Center for Drug Evaluation and Research (CDER) and requestors and sponsors of drugs that will be subject to a final administrative order under section 505G of the Federal Food, Drug, and Cosmetic Act (FD&C Act) ("Final Order"). This guidance finalizes the draft guidance of the same title issued on June 23, 2023.
This is a notice published in the Federal Register by Health and Human Services Department, Food and Drug Administration. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.
This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.
Notice of availability.
The announcement of the guidance is published in the Federal Register on December 23, 2025.
| Document Number | 2025-23707 |
| FR Citation | 90 FR 60104 |
| Type | Notice |
| Published | Dec 23, 2025 |
| Effective Date | - |
| RIN | - |
| Docket ID | Docket No. FDA-2023-D-2204 |
| Pages | 60104–60106 (3 pages) |
| Text Fetched | No |
| Part | Name | Agency |
|---|---|---|
| No linked CFR parts | ||
| Type | Proposed | Final | Method | Conf |
|---|---|---|---|---|
| No paired documents | ||||
The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.